Advertisement
Home Tags Drug Approvals

Tag: Drug Approvals

Xadago (safinamide) tablets have been approved by the U.S. Food and Drug Administration as an add-on drug to treat Parkinson's patients who take levodopa or carbidopa but experience "off" episodes.

FDA Approves New Parkinson’s Add-On Drug Xadago

0
To help prevent 'off' episodes among users of levodopa/carbidopa
Noctiva (desmopressin acetate) nasal spray has been approved by the U.S. Food and Drug Administration to treat frequent urination at night due to nocturnal polyuria.

FDA Approves Noctiva Nasal Spray for Nocturnal Polyuria

0
Drug designed to increase absorption of water through the kidneys, decreasing urine production
A new treatment for dust mite allergies has been approved by the U.S. Food and Drug Administration.

FDA Approves Odactra for House Dust Mite Allergies

0
Year-round, once-a-day tablet that's taken sublingually
Xermelo (telotristat ethyl) tablets have been approved by the U.S. Food and Drug Administration to treat adults with carcinoid syndrome diarrhea.

FDA Approves Xermelo for Carcinoid Syndrome Diarrhea

0
Oral tablets to be used in combination with somatostatin analog therapy
The injected drug Siliq (brodalumab) has been approved by the U.S. Food and Drug Administration to treat moderate-to-severe plaque psoriasis in adults.

FDA Approves Siliq for Plaque Psoriasis

0
Injected medication approved for use by patients who've failed other treatments
Emflaza (deflazacort) has been approved by the U.S. Food and Drug Administration to treat Duchenne muscular dystrophy in patients 5 years and older

FDA Approves Emflaza for Duchenne Muscular Dystrophy

0
Approved to treat Duchenne muscular dystrophy in patients 5 years and older
A set of screening tests designed to detect four rare metabolic disorders in newborns has been approved by the U.S. Food and Drug Administration.

FDA Approves Newborn Screening Tests for Metabolic Disorders

0
Screens used to detect Mucopolysaccharidosis Type 1, Pompe, Gaucher, and Fabry
Trulance has been approved by the U.S. Food and Drug Administration to treat persistent idiopathic constipation in adults.

FDA Approves Trulance for Chronic Idiopathic Constipation

0
Drug designed to stimulate secretion of intestinal fluid
The drug Rubraca (rucaparib) has been granted accelerated approval by the U.S. Food and Drug Administration to treat advanced ovarian cancer.

FDA Grants Fast-Track Approval to Ovarian Cancer Drug

0
Rubraca's use is specific to women with deleterious BRCA mutations
Maci (autologous cultured chondrocytes on porcine collagen membrane) has been approved by the U.S. Food and Drug Administration to repair symptomatic

FDA OKs Autologous Cellularized Scaffold for Knee Cartilage Repair

0
For symptomatic, full-thickness cartilage defects of the knee in adult patients